First Trust Investment Solutions L.P. Regeneron Pharmaceuticals, Inc. Transaction History
First Trust Investment Solutions L.P.
- $568 Billion
- Q1 2024
A detailed history of First Trust Investment Solutions L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, First Trust Investment Solutions L.P. holds 229 shares of REGN stock, worth $243,564. This represents 0.04% of its overall portfolio holdings.
Number of Shares
229
Previous 229
-0.0%
Holding current value
$243,564
Previous $201 Million
9.59%
% of portfolio
0.04%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,437Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.5 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$9.11 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$8.22 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.15 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.95 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $114B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...